The effect of Probiotics in treatment of neonetal jaundice

Phase 2

• Conditions: Condition 1: Neonatal Jaundice. Condition 2: Neonatal Jaundice.; Newborn/ Neonatal Diagnoses; Newborn/ Neonatal Diagnosis

• Registration Number: IRCT2017042733661N1
• Lead Sponsor: Vice Chancellor for Research, Alborz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

gestational age (42-37 weeks); jaundice (physiological and non-physiological).
Exclusion criteria:Infection; SEPSIS; Hypothyroidism; History the blood transfusion.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eonatal Jaundice. Timepoint: Dqily. Method of measurement: Blood test.

Secondary Outcome Measures

Name	Time	Method
Duration of treatment of Neonatal Jaundice. Timepoint: Discharge Time. Method of measurement: The number of days of hospitalization records.